Brenda Armenti-Kapros, MD
Endocrinology · Mechanicsville, VANPI 1689642464
Payments from drug & device makers
Across 613 payments — averaging $125.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$44K
- AstraZeneca$14K
- Merck$5K
- Zealand Pharma US, Inc.$4K
- Intuity Medical Inc$3K
- Lilly USA, LLC$1K
- plus $6K from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 110 | $43,847 |
| AstraZeneca | 125 | $13,692 |
| Merck | 22 | $5,211 |
| Zealand Pharma US, Inc. | 39 | $3,990 |
| Intuity Medical Inc | 1 | $2,800 |
| Lilly USA, LLC | 58 | $1,203 |
| Valeritas, Inc. | 34 | $803 |
| Abbott | 36 | $679 |
| Amgen | 21 | $595 |
| Bayer | 9 | $358 |
| Sanofi-aventis U.S. LLC | 15 | $340 |
| Mannkind Corporation | 16 | $329 |
| AbbVie | 16 | $312 |
| Dexcom, Inc. | 8 | $255 |
| Medtronic(2 entities) | 15 | $254 |
| Insulet Corporation | 5 | $242 |
| Radius Health, Inc. | 7 | $187 |
| Xeris Pharmaceuticals, Inc. | 6 | $183 |
| Cequr Corporation | 2 | $179 |
| Amneal Pharmaceuticals LLC | 11 | $177 |
| Antares Pharma, Inc. | 8 | $151 |
| Boehringer Ingelheim | 8 | $149 |
| Lifescan, Inc. | 5 | $117 |
| Tandem Diabetes Care, Inc. | 8 | $115 |
| Astellas Pharma US Inc | 3 | $113 |
| AMAG Pharmaceuticals, Inc. | 1 | $99 |
| Clarus Therapeutics Inc. | 1 | $83 |
| Tolmar, Inc. | 4 | $65 |
| IBSA Pharma Inc. | 3 | $58 |
| Novartis | 2 | $46 |
| Eisai Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Shire North American Group Inc | 2 | $30 |
| Johnson & Johnson | 2 | $29 |
| Pfizer | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Halozyme Inc | 1 | $21 |
| Recordati_rare_diseases_inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Acella Pharmaceuticals, LLC | 1 | $13 |
How this compares
Too few endocrinology providers in Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology in Mechanicsville
- Elizabeth BondChristiansburg$7K
- Sarasi JayaratneAlexandria$0
- Peter RossFairfax$0
- Deepak KashyapFalls Church$0
- Heather FerrisCharlottesville$0
- Kate KinnairdFalls Church$0
- Jeffrey TaylorHarrisonburg$0
- Mandip RawlaNorfolk$0
- Christopher McCartneyCharlottesville$0
- Lida TabatabaeianWarrenton$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.